Insider · CIK 0001896079
Michael J. Carson
Files at NVCT (Nuvectis Pharma, Inc.). First filing Nov 8, 2024, latest Nov 8, 2024.
In brief
Michael J. Carson files SEC Form 4 as officer at NVCT (Nuvectis Pharma, Inc.). Since Nov 8, 2024, Michael J. Carson has reported 0 open-market buys worth $0 and 1 open-market sell worth $22k, the latest filed on Nov 8, 2024.
A track record needs three past buys with six months of prices behind them; Michael J. Carson has 0, so none is measured yet.
The newest scored trade: sold $22k of NVCT on Nov 7, 2024, filed Nov 8, 2024, scored 15 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NVCT: Nuvectis Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 230,118 | Aug 5, 2026 |
| Jan 6, 2026 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +61,200 | $0.00 | $0 | 200,118 | Jan 9, 2026 |
| Jan 2, 2025 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +51,000 | $0.00 | $0 | 138,918 | Jan 3, 2025 |
| Jan 3, 2023 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +28,806 | $0.00 | $0 | 56,106 | Nov 8, 2024 |
| Jan 4, 2024 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +34,567 | $0.00 | $0 | 90,673 | Nov 8, 2024 |
| Nov 7, 2024 | NVCT Nuvectis Pharma, Inc. | SOpen-market sale Common Stock | -2,755 | $8.16 | $22k | 87,918 | Nov 8, 2024 |
Questions about Michael J. Carson
Answered from the filings on this page, as of the latest one.
Is Michael J. Carson buying or selling?
Not in the last 12 months. Michael J. Carson's latest open-market trade on SEC Form 4 was sold $22k of NVCT on Nov 7, 2024.
How did Michael J. Carson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael J. Carson has 0.
Where does Michael J. Carson file Form 4?
Michael J. Carson has filed Form 4 at NVCT (Nuvectis Pharma, Inc.) as Vice President, Finance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.